Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risks of Intermittent Fasting in Patients With Primary Adrenal Insufficiency

NCT06299020 is registered in ClinicalTrials.gov with Hopital La Rabta as lead sponsor.

NCT NCT06299020
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06299020 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risks of Intermittent Fasting in Patients With Primary Adrenal Insufficiency
Lead sponsor
Hopital La Rabta
Phase
Not applicable
Overall status
Completed
Start date
March 4, 2024
Completion date
December 1, 2024
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intermittent fasting, primary adrenal insufficiency